Clinical Trial Update: A Study of PER-001 in Participants With Open-Angle Glaucoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for PER-001 in open-angle glaucoma, showing Phase 1 and Phase 2 studies that are currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• PER-001

Snippet

Sponsor: Perfuse Therapeutics, Inc. | Conditions: Open-angle Glaucoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING